drugset / Trial / NCT05296213

Medical Treatment of Early-Enamel Carious Lesion Using Different Remeneralizing Agents

NCT05296213

Completed 45 enrolled Mansoura University
RandomizedParallel-groupTriple-blindTreatment

Summary

Medical Treatment of Early-Enamel Carious Lesion using Different Remeneralizing agents

Timeline

Start
2019-12-01
Primary completion
2021-12-10
Completion
2022-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Biodentine Other / unclassified
Subject Casein phosphopeptide amorphous calcium phosphate Peptide Topical
Subject silver diammine fluoride Small molecule Topical

Indications